Thrombin Inhibition Is Impaired in Plasma of Sick Neonates

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Pediatric Research

• Publication date

  1992-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1203/00006450-199204000-00017PMID 1373886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.

  1992cited by this paper
• Development of the Hemostatic System in the Neonate and Young Infant

  1990cited by this paper
• Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin

  1990cited by this paper
• Alpha-2-Macroglobulin Is an Important Progressive Inhibitor of Thrombin in Neonatal and Infant Plasma

  1989cited by this paper
• Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.

  1989cited by this paper
• Anticoagulant Effects of Heparin in Neonatal Plasma'

  1989cited by this paper
• The Relative Importance of the Factors II, VII, IX and X for the Prothrombinase Activity in Plasma of Orally Anticoagulated Patients

  1989cited by this paper
• Heparin Cofactor II, Antithrombin and Protein C in Plasma from Term and Preterm Infants

  1988cited by this paper
• Development of the human coagulation system in the healthy premature infant.

  1988cited by this paper
• Development of the human coagulation system in the full-term infant.

  1987cited by this paper
• Coagulation disorders in the neonate.

  1986cited by this paper
• A Human Pharmacological Study Comparing Conventional Heparin and a Low Molecular Weight Heparin Fragment

  1985cited by this paper
• ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.

  1985cited by this paper
• Low Antithrombin III Levels in Neonates with Idiopathic Respiratory Distress Syndrome: Poor Prognosis

  1984cited by this paper
• Plasma Protease Inhibitors in Premature Infants: Influence of Gestational Age, Postnatal Age, and Health Status 1

  1983cited by this paper
• Acquired haemostatic defects in the ill newborn

  1983cited by this paper
• Respective Roles of Antithrombin III and Alpha 2 Macroglobulin in Thrombin Inactivation

  1981cited by this paper
• Coagulation changes in the newborn with respiratory failure.

  1980cited by this paper
• Activation of coagulation and disseminated intravascular coagulation in the newborn.

  1979cited by this paper
• Neonatal thrombosis.

  1979cited by this paper
• Pulmonary hypertension in the perinatal aspiration syndromes.

  1977cited by this paper
• Hyaline membrane disease.

  1975cited by this paper
• Circulating Anticoagulants in the Newborn: Relation to Hypercoagulability and the Idiopathic Respiratory Distress Syndrome

  1973cited by this paper
• Evolution of Blood Clotting Factor Levels in Premature Infants during the First 10 Days of Life: A Study of 96 Cases with Comparison Between Clinical Status and Blood Clotting Factor Levels

  1973cited by this paper
• Disseminated intravascular coagulation in the respiratory distress syndrome.

  1973cited by this paper
• Coagulation Studies in Preterm Infants with Respiratory Distress and Intracranial Haemorrhage*

  1972cited by this paper
• Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. I. Coagulation studies.

  1971cited by this paper
• Disseminated intravascular coagulation in the newborn.

  1969cited by this paper
• Disseminated fibrin thromboembolism among neonates dying within 48 hours of birth.

  1967cited by this paper
• Coagulation Factors in Pregnant Women and Premature Infants with and without the Respiratory Distress Syndrome

  1967cited by this paper
• Transient tachypnea of newborn. Possible delayed resorption of fluid at birth.

  1966cited by this paper

• Thrombin generation in children using ThromboScreen reagent kit with ST Genesia—A pilot study

  2021cites this paper
• Role of Platelets in Neonatal Necrotizing Enterocolitis

  2020cites this paper
• Anticoagulation in preterm and term neonates: Why are they special?

  2019cites this paper
• The Thrombotic Risk of the Newborn

  2018cites this paper
• Antithrombotic therapy in pediatric ventricular assist devices: Multicenter survey of the European EXCOR Pediatric Investigator Group

  2018cites this paper
• Thromboses néonatales sur cathéters épicutanéocaves : évaluation rétrospective des facteurs de risque, du traitement et de l'évolution à partir de 14 cas entre 2013 et 2014

  2016cites this paper
• To Characterize Standard Laboratory Coagulation Parameters and Plasma Thrombin Generation in Very Preterm Infants and to Investigate Their Relationship to Clinical Outcomes

  2014cites this paper
• Increased Risk for Thrombosis Short-Term Use of Umbilical Artery Catheters May Not Be Associated With

  2013cites this paper
• The coagulation system in humans.

  2013cites this paper
• Age-related differences in thrombin generation using a mathematical model

  2013cites this paper
• Topical Nitroglycerine for Neonatal Arterial Associated Peripheral Ischemia following Cannulation: A Case Report and Comprehensive Literature Review

  2013cites this paper
• Coagulation Disorders: Risk of Thrombosis in the Newborn

  2012cites this paper
• The preterm infant with thrombosis

  2012cites this paper
• Principles of hemostasis in children: models and maturation

  2011cites this paper
• Thrombin regulation in newborn infants

  2007influential citation
• Study of Some Aspects of the Coagulation System in Neonatal Septicemia

  2007cites this paper
• THROMBIN REGULATION IN NEWBORN INFANTS

  2007influential citation
• Iliofemoral deep vein thrombosis in childhood; developing a management protocol.

  2006cites this paper
• Clinical Measures of Heparin’s Effect and Thrombin Inhibitor Levels in Pediatric Patients with Congenital Heart Disease

  2006cites this paper
• Volutrauma activates the clotting cascade in the newborn but not adult rat.

  2006cites this paper
• newborn but not adult rat Volutrauma activates the clotting cascade in the

  2006cites this paper
• Chapter 76 – Hemostatic Disorders of the Newborn

  2005cites this paper
• An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography

  2005cites this paper
• Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cites this paper
• Risk factors for venous thromboembolism in children.

  2004cites this paper
• Short-term use of umbilical artery catheters may not be associated with increased risk for thrombosis.

  2004cites this paper
• Antithrombin III in the Diagnosis and Treatment of Disseminated Intravascular Coagulation in Premature Infants

  2004cites this paper
• Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates

  2003cites this paper
• Anticoagulation Therapy in Children

  2003cites this paper
• Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential

  2002cites this paper
• Antithrombotic therapy in children.

  2001cites this paper
• Effects of alpha(2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma.

  2001cites this paper
• Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns

  2000cites this paper
• Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma.

  1999cites this paper
• Effekt von Protein C und ATIII auf das Thrombinpotential im Neugeborenenplasma

  1999cites this paper
• Application of Image Analysis Techniques to Two-dimensional Crossed Immunoelectrophoresis Study

  1999cites this paper
• Uses of antithrombin III concentrate in congenital and acquired deficiency states

  1998cites this paper
• Coagulation and fibrinolytic systems in the ill preterm newborn

  1997cites this paper
• stickiness of newborn .'rmal barrier skin: Bioadhesion and the

  1997cites this paper
• Thromboembolic Risks and Complications in Nephrotic Children

  1997cites this paper
• Safety of heparin use in the premature infant.

  1997cites this paper
• Decreased Thrombin Activity of Fibrin Clots Prepared in Cord Plasma Compared with Adult Plasma

  1996cites this paper
• Platelet activation in newborns detected by flow-cytometry.

  1996cites this paper
• Developmental Hemostasis: Relevance to Thromboembolic Complications in Pediatric Patients

  1995cites this paper
• Developmental Hemostasis: Relevance to Hemostatic Problems During Childhood

  1995influential citation
• Antithrombotic therapy in children.

  1995cites this paper
• Thrombin Regulation in Children Differs from Adults in the Absence and Presence of Heparin

  1994cites this paper
• Influence of lung maturity on bronchoalveolar fibrin deposition and clearance in lung injury syndromes.

  1994cites this paper
• Activation of the Plasma Clotting, Fibrinolytic, and Kinin-Kallikrein System in Preterm Infants with Severe Idiopathic Respiratory Distress Syndrome

  1994cites this paper
• Thrombin inhibition by fetal distal lung epithelium is different in fetal and adult plasma.

  1994cites this paper
• Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates.

  1993cites this paper
• A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants.

  1993cites this paper
• Inhibition and restoration of hemostasis in the young cardiac surgical patient

  1993cites this paper